Bottles of a trial Covid-19 vaccine on a table in a lab in Brussels on June 18, 2020.
Credit: Vincent Kalut/Photonews/Getty 

Government contracts obtained by consumer advocacy group Knowledge Ecology International show that the Trump administration is giving pharmaceutical companies a green light to charge exorbitant prices for potential coronavirus treatments developed with taxpayer money by refusing to exercise federal authority to constrain costs.

“The government has limited its ability to intervene if the pharmaceutical companies… charge unreasonable prices for the resulting Covid-19 vaccines or treatments.”
—Knowledge Ecology International

Through the Freedom of Information Act, Knowledge Ecology International (KEI) last week got hold of a number of heavily redacted agreements between the Trump administration and major pharmaceutical companies like Johnson & Johnson, Regeneron, and Genentech.

Five of the seven documents reviewed by KEI are classified as “other transaction agreements,” which allow federal agencies to loosen regulations designed to protect the public in order to help companies streamline the product development process.

In the case of four contracts for potential Covid-19 treatments or vaccines with Johnson & Johnson, Genentech, Regeneron, and Roche issued by the Biomedical Advanced […]

Read the Full Article